Contact this trialFirst, we need to learn more about you.
Anti-metabolites
Cladribine Tablets for Multiple Sclerosis
Recruiting3 awardsPhase 4
Latham, New York
This trial will test if a biomarker can be used to detect activity in Multiple Sclerosis and if it can be used to adjust treatment to prevent dysfunction.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.